LIMPRINT in Specialist lymphedema services in United Kingdom, France, Italy, and Turkey
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
LIMPRINT in Specialist lymphedema services in United Kingdom, France, Italy, and Turkey. / Keeley, Vaughan; Franks, Peter; Quere, Isabelle; Mercier, Gregoire; Michelini, Sandro; Cestari, Marina; Borman, Pinar; Hughes, Andrew; Clark, Kath; Lisle, Jill; Benson, Margaret; Noerregaard, Susan; Karlsmark, Tonny; Murray, Susie; Moffatt, Christine.
I: Lymphatic Research and Biology, Bind 17, Nr. 2, 2019, s. 141-146.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - LIMPRINT in Specialist lymphedema services in United Kingdom, France, Italy, and Turkey
AU - Keeley, Vaughan
AU - Franks, Peter
AU - Quere, Isabelle
AU - Mercier, Gregoire
AU - Michelini, Sandro
AU - Cestari, Marina
AU - Borman, Pinar
AU - Hughes, Andrew
AU - Clark, Kath
AU - Lisle, Jill
AU - Benson, Margaret
AU - Noerregaard, Susan
AU - Karlsmark, Tonny
AU - Murray, Susie
AU - Moffatt, Christine
PY - 2019
Y1 - 2019
N2 - Background: There is no standardized international model for specialist lymphedema services, which covers the types of lymphedema treated and the treatments provided. The aim of this study was to provide a profile of patients attending specialist lymphedema services in different countries to explore similarities and differences. Methods and Results: The LIMPRINT core tool was used in specialist lymphedema services in the United Kingdom, France, Italy, and Turkey. Services in Turkey saw a slightly younger age group, with a higher proportion of female patients reflecting a particular focus on breast cancer-related lymphedema. There were higher levels of obesity and restricted mobility in patients in the United Kingdom compared with other countries. Italy and France saw the highest percentage of patients with primary lymphedema. Diabetes was a common comorbidity in the United Kingdom and Turkey. The United Kingdom saw the largest number of patients with lower limb lymphedema. Conclusions: The results show a wide range of complexity of patients treated in specialist lymphedema services. Some of the differences between countries may reflect different stages in the evolution of specialist lymphedema services, rather than a true difference in prevalence, with those with "younger" services treating a high proportion of patients with cancer and those with more established services treating a wider range of different types of lymphedema, including more elderly people with multiple comorbidities.
AB - Background: There is no standardized international model for specialist lymphedema services, which covers the types of lymphedema treated and the treatments provided. The aim of this study was to provide a profile of patients attending specialist lymphedema services in different countries to explore similarities and differences. Methods and Results: The LIMPRINT core tool was used in specialist lymphedema services in the United Kingdom, France, Italy, and Turkey. Services in Turkey saw a slightly younger age group, with a higher proportion of female patients reflecting a particular focus on breast cancer-related lymphedema. There were higher levels of obesity and restricted mobility in patients in the United Kingdom compared with other countries. Italy and France saw the highest percentage of patients with primary lymphedema. Diabetes was a common comorbidity in the United Kingdom and Turkey. The United Kingdom saw the largest number of patients with lower limb lymphedema. Conclusions: The results show a wide range of complexity of patients treated in specialist lymphedema services. Some of the differences between countries may reflect different stages in the evolution of specialist lymphedema services, rather than a true difference in prevalence, with those with "younger" services treating a high proportion of patients with cancer and those with more established services treating a wider range of different types of lymphedema, including more elderly people with multiple comorbidities.
KW - LIMPRINT
KW - primary lymphedema
KW - secondary lymphedema
KW - specialist lymphedema services
U2 - 10.1089/lrb.2019.0021
DO - 10.1089/lrb.2019.0021
M3 - Journal article
C2 - 30995195
AN - SCOPUS:85064711820
VL - 17
SP - 141
EP - 146
JO - Lymphatic Research and Biology
JF - Lymphatic Research and Biology
SN - 1539-6851
IS - 2
ER -
ID: 241210790